These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 18624901

  • 1. Glycine N-methyltransferase is a favorable prognostic marker for human cholangiocarcinoma.
    Huang YC, Chen M, Shyr YM, Su CH, Chen CK, Li AF, Ho DM, Chen YM.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1384-9. PubMed ID: 18624901
    [Abstract] [Full Text] [Related]

  • 2. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ, Lang H, Kaiser G, Wohlschlaeger J, Sotiropoulos GC, Baba HA, Jasani B, Schmid KW.
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
    Maeda T, Taguchi K, Aishima S, Shimada M, Hintz D, Larusso N, Gores G, Tsuneyoshi M, Sugimachi K, Wands JR, de la Monte SM.
    Cancer Detect Prev; 2004 Dec; 28(5):313-8. PubMed ID: 15542253
    [Abstract] [Full Text] [Related]

  • 6. Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma.
    Thelen A, Scholz A, Weichert W, Wiedenmann B, Neuhaus P, Gessner R, Benckert C, Jonas S.
    Am J Gastroenterol; 2010 May; 105(5):1123-32. PubMed ID: 19997097
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T, Aishima S, Taketomi A, Nishihara Y, Fujita N, Sanefuji K, Sugimachi K, Yamashita Y, Maehara Y, Tsuneyoshi M.
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [Abstract] [Full Text] [Related]

  • 9. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
    Lang H, Sotiropoulos GC, Sgourakis G, Schmitz KJ, Paul A, Hilgard P, Zöpf T, Trarbach T, Malagó M, Baba HA, Broelsch CE.
    J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Nuclear survivin expression predicts poor outcome in cholangiocarcinoma.
    Javle MM, Tan D, Yu J, LeVea CM, Li F, Kuvshinoff BW, Gibbs JF.
    Hepatogastroenterology; 2004 Feb; 51(60):1653-7. PubMed ID: 15532797
    [Abstract] [Full Text] [Related]

  • 12. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
    Romani AA, Crafa P, Desenzani S, Graiani G, Lagrasta C, Sianesi M, Soliani P, Borghetti AF.
    BMC Cancer; 2007 Dec 21; 7():232. PubMed ID: 18154639
    [Abstract] [Full Text] [Related]

  • 13. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM, Yu J, Khoury T, Chadha KS, Iyer RV, Foster J, Kuvshinoff BW, Gibbs JF, Geradts J, Black JD, Brattain MG.
    J Gastroenterol Hepatol; 2006 Nov 21; 21(11):1744-51. PubMed ID: 16984600
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.
    J Surg Oncol; 2007 Mar 01; 95(3):207-12. PubMed ID: 17278119
    [Abstract] [Full Text] [Related]

  • 16. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S, Asayama Y, Taguchi K, Sugimachi K, Shirabe K, Shimada M, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 2002 Nov 01; 15(11):1181-90. PubMed ID: 12429797
    [Abstract] [Full Text] [Related]

  • 17. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T, Shimada K, Sakamoto Y, Ojima H, Esaki M, Kosuge T.
    Ann Surg Oncol; 2008 Feb 01; 15(2):590-9. PubMed ID: 18057991
    [Abstract] [Full Text] [Related]

  • 18. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.
    Schmitz KJ, Lang H, Wohlschlaeger J, Reis H, Sotiropoulos GC, Schmid KW, Baba HA.
    Virchows Arch; 2007 Feb 01; 450(2):135-41. PubMed ID: 17165088
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q, Wang JM, Liu C, Xiao BL, Lu JX, Zou SQ.
    Hepatobiliary Pancreat Dis Int; 2008 Feb 01; 7(1):70-5. PubMed ID: 18234642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.